119 related articles for article (PubMed ID: 1016967)
1. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. II. Effects on macromolecular synthesis in cell culture and evidence for alkylating activity.
Brockman RW; Shaddix SC; Williams M; Struck RF
Cancer Treat Rep; 1976 Sep; 60(9):1317-24. PubMed ID: 1016967
[TBL] [Abstract][Full Text] [Related]
2. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. I. Cell kinetic and biologic effects in cultured L1210, human epidermoid No. 2, and adenocarcinoma 755 cells.
Wheeler GP; Bono VH; Bowdon BJ; Adamson DJ; Wallace R
Cancer Treat Rep; 1976 Sep; 60(9):1307-16. PubMed ID: 1035133
[TBL] [Abstract][Full Text] [Related]
3. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
[TBL] [Abstract][Full Text] [Related]
4. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.
Bhuyan BK; Newell KA; Crampton SL; Von Hoff DD
Cancer Res; 1982 Sep; 42(9):3532-7. PubMed ID: 7105029
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture.
Plagemann PG; Graff JC; Behrens M
Cancer Res; 1977 Jul; 37(7 Pt 1):2188-95. PubMed ID: 193637
[TBL] [Abstract][Full Text] [Related]
6. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
Glazer RI; Hartman KD; Knode MC
Mol Pharmacol; 1983 Sep; 24(2):309-15. PubMed ID: 6888372
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.
Howard RA; Kimball AP; Bear JL
Cancer Res; 1979 Jul; 39(7 Pt 1):2568-73. PubMed ID: 445459
[TBL] [Abstract][Full Text] [Related]
8. Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.
Momparler RL; Karon M; Siegel SE; Avila F
Cancer Res; 1976 Aug; 36(8):2891-5. PubMed ID: 1277199
[TBL] [Abstract][Full Text] [Related]
9. CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA.
Li LH; Swenson DH; Schpok SL; Kuentzel SL; Dayton BD; Krueger WC
Cancer Res; 1982 Mar; 42(3):999-1004. PubMed ID: 6174220
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and mechanism of action of 6-thio-3-deazaguanine.
Mian AM; Furusawa S
Cancer Res; 1987 Apr; 47(7):1863-6. PubMed ID: 3815377
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
Hall IH; Williams WL; Grippo AA; Lee KH; Holbrook DJ; Chaney SG
Anticancer Res; 1988; 8(1):33-42. PubMed ID: 2895992
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent synergistic cytotoxicity of arabinofuranosylcytosine with adriamycin or 3,6-bis(5-chloro-2-piperidinyl)-2,5-piperazinedione in cultured cells.
Rao PN; Mahagaokar S; Freireich EJ; Loo TL; Gottlieb JA
Cancer Res; 1975 Nov; 35(11 Pt 1):2996-3000. PubMed ID: 1182694
[TBL] [Abstract][Full Text] [Related]
13. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
Beal DD; Skibba JL; Whitnable KK; Bryan GT
Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of DNA and RNA synthesis by neocarzinostatin in cultured Burkitt lymphoma cells.
Kawai Y; Katoh A
J Natl Cancer Inst; 1972 May; 48(5):1535-8. PubMed ID: 5030963
[No Abstract] [Full Text] [Related]
16. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Glazer RI; Hartman KD
Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
[No Abstract] [Full Text] [Related]
17. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
Schlager SI; Boyle MD; Ohanian SH; Borsos T
Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
[TBL] [Abstract][Full Text] [Related]
18. Mode of action of the bioreductive alkylating agent, 2,3-bis(chloromethyl)-1,4-naphthoquinone.
Cosby LA; Pardini RS; Biagini RE; Lambert TL; Lin AJ; Huang YM; Hwang KM; Sartorelli AC
Cancer Res; 1976 Nov; 36(11 Pt 1):4023-31. PubMed ID: 184923
[TBL] [Abstract][Full Text] [Related]
19. Biological and biochemical effects of chartreusin on mammalian cells.
Li LH; Clark TD; Murch LL; Wooden JM; Pschigoda LM; Krueger WC
Cancer Res; 1978 Sep; 38(9):3012-8. PubMed ID: 567097
[No Abstract] [Full Text] [Related]
20. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
Fernandez-Pol JA; Klos DJ; Hamilton PD
Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
